Aytekin Faruk Onder, Teke Zafer, Aydin Cagatay, Kabay Burhan, Yenisey Cigdem, Sacar Suzan, Demir Ece Mine, Tekin Koray
Faculty of Medicine, Department of General Surgery, Pamukkale University, 20070 Kinikli, Denizli, Turkey.
Am J Surg. 2007 Jun;193(6):723-9. doi: 10.1016/j.amjsurg.2006.06.035.
Tempol (Sigma-Aldrich, Steinheim, Germany) is a stable piperidine nitroxide of low molecular weight that permeates biologic membranes and scavenges superoxide anions in vitro. In recent animal studies, the delaying effect of intraperitoneal sepsis on the healing of colonic anastomoses has been shown. In this study we aimed to investigate the effects of Tempol on the healing of colonic anastomoses in the presence of polymicrobial sepsis.
Anastomosis of the left colon was performed on the day after cecal ligation and puncture (CLP) in 30 rats that were divided into 3 groups: sham-operated control (laparotomy and cecal mobilization, group I, n = 10), CLP (group II, n = 10), Tempol-treated group (30 mg/kg intravenously before the construction of colonic anastomosis, group III, n = 10). On postoperative day 6, all animals were killed and anastomotic bursting pressures were measured in vivo. Tissue samples were obtained for further investigation of anastomotic hydroxyproline (HP) contents, perianastomotic myeloperoxidase (MPO) activity, malondialdehyde (MDA), and glutathione (GSH) levels.
There was a statistically significant increase in MPO activity and MDA levels in the CLP group (group II), along with a decrease in GSH levels, anastomotic HP contents, and bursting pressure values when compared with controls (group I). However, Tempol treatment led to a statistically significant increase in anastomotic bursting pressure values, tissue HP contents, and GSH levels, along with a decrease in MPO activity and MDA levels in group III (P < .05).
This study showed that Tempol treatment significantly prevented the delaying effect of CLP-induced polymicrobial sepsis on anastomotic healing in the left colon. Further clinical studies are needed to clarify whether Tempol may be a useful therapeutic agent to increase the safety of the anastomosis during particular surgeries in which sepsis-induced organ injury occurs.
Tempol(德国施泰因海姆西格玛奥德里奇公司)是一种低分子量的稳定哌啶氮氧化物,可穿透生物膜并在体外清除超氧阴离子。最近的动物研究表明,腹腔内脓毒症对结肠吻合口愈合有延迟作用。在本研究中,我们旨在探讨Tempol在多微生物脓毒症存在的情况下对结肠吻合口愈合的影响。
对30只大鼠进行盲肠结扎和穿刺(CLP)后次日行左半结肠吻合术,将其分为3组:假手术对照组(剖腹术和盲肠游离,I组,n = 10)、CLP组(II组,n = 10)、Tempol治疗组(结肠吻合术构建前静脉注射30 mg/kg,III组,n = 10)。术后第6天,处死所有动物,在体内测量吻合口破裂压力。获取组织样本以进一步研究吻合口羟脯氨酸(HP)含量、吻合口周围髓过氧化物酶(MPO)活性、丙二醛(MDA)和谷胱甘肽(GSH)水平。
与对照组(I组)相比,CLP组(II组)的MPO活性和MDA水平有统计学意义的升高,同时GSH水平、吻合口HP含量和破裂压力值降低。然而,Tempol治疗导致III组的吻合口破裂压力值、组织HP含量和GSH水平有统计学意义的升高,同时MPO活性和MDA水平降低(P < 0.05)。
本研究表明,Tempol治疗可显著预防CLP诱导的多微生物脓毒症对左半结肠吻合口愈合的延迟作用。需要进一步的临床研究来阐明Tempol是否可能是一种有用的治疗药物,以提高在发生脓毒症诱导器官损伤的特定手术中吻合口的安全性。